Metaplanet
3350
Mitsui O.S.K. Lines
9104
Oriental Land
4661
4
Toyota Motor
7203
5
Nippon Telegraph & Telephone
9432
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 40
- +1+2.56%
20min DelayMarket Closed Apr 30 15:30 JST
3.62BMarket Cap-2.20P/E (Static)
40High39Low1.76MVolume39Open39Pre Close69.24MTurnover8952wk High2.05%Turnover Ratio90.49MShares3252wk Low-16.51EPS TTM3.44BFloat Cap2229Historical HighLossP/E (Static)85.94MShs Float32Historical Low-18.21EPS LYR2.56%Amplitude--Dividend TTM2.86P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --